NIH-funded research R01 grant

Modeling liver toxicity using advanced computational techniques

Official title: Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity

Funded at Tulane University of Louisiana · NIH-10997329 · Data updated 2026-11-12

This study is working on new computer models to help predict if new medicines and chemicals could harm the liver, so we can find out faster and more accurately without relying as much on animal testing.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startNovember 16, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$450,989
NIH project number5R01ES031080-06
Project IDNIH-10997329 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are involved in drug development or are exposed to industrial chemicals and environmental pollutants.

Less likely to help

Patients who are not involved in drug development or who do not have exposure to relevant chemicals may not benefit from this research.

What this research studies

This research focuses on developing innovative computational models to predict liver toxicity (hepatotoxicity) of new drugs and environmental chemicals. By utilizing a mechanism-driven Virtual Adverse Outcome Pathway (vAOP) approach, the study aims to enhance the accuracy and speed of toxicity assessments, reducing the reliance on traditional animal testing. The project will validate these models through a combination of in vitro and ex vivo testing, ultimately aiming to create a high-throughput screening method for evaluating the safety of various compounds.

Why it matters

Potential benefit: If successful, this research could lead to faster and more reliable assessments of drug and chemical safety, potentially reducing harmful side effects for patients.

How similar studies have gone: Previous research has shown promise in using computational models for toxicity prediction, indicating that this approach could lead to significant advancements in safety assessments.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Zhu, Hao — Tulane University of Louisiana
  • Study coordinator: Zhu, Hao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.